| Jill Kristie Bandalan Sim, | |
|
3430 E La Palma Ave, Bldg 2 Flr 1, Anaheim, CA 92806-2020 | |
| (714) 644-7180 | |
| (714) 644-7183 |
| Full Name | Jill Kristie Bandalan Sim |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3430 E La Palma Ave, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053842401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 59725 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jill Kristie Bandalan Sim, 3430 E La Palma Ave, Bldg 2 Flr 1, Anaheim, CA 92806-2020 Ph: () - | Jill Kristie Bandalan Sim, 3430 E La Palma Ave, Bldg 2 Flr 1, Anaheim, CA 92806-2020 Ph: (714) 644-7180 |
News Archive
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.
"We commend the 130th session of the WHO Executive Board for adopting a resolution calling for a comprehensive response to the global burden of mental illnesses," Rebecca Hock of the Johns Hopkins Bloomberg School of Public Health's Department of Mental Health, and colleagues, write in this Lancet opinion piece.
Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.
In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a study in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment.
› Verified 5 days ago
Tarjani Lalitkumar Padmani, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 735 S Dove Tree Ln, Anaheim, CA 92808 Phone: 714-280-0825 | |
John Wang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 E Orangethorpe Ave, Anaheim, CA 92801 Phone: 714-626-0014 | |
Mohamed Hussein, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1807 W Katella Ave Ste 206, Anaheim, CA 92804 Phone: 714-733-7978 Fax: 714-733-7969 | |
Kasey Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 E Lincoln Ave Ste B, Anaheim, CA 92805 Phone: 714-776-1020 Fax: 714-776-7053 | |
Dr. Lan-phuong Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 N Lakeview Ave, Kaiser Permanente Anticoagulation Service, Anaheim, CA 92807 Phone: 714-279-5403 Fax: 714-279-4809 | |
Hanny M Tadros, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 S Brookhurst St, Anaheim, CA 92804 Phone: 714-778-3123 | |
Atoussa Najafian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-491-1778 |